首页> 外文期刊>Gut: Journal of the British Society of Gastroenterology >Scheduled endoscopic surveillance controls secondary cancer after curative endoscopic resection for early gastric cancer: A multicentre retrospective cohort study by Osaka University ESD study group
【24h】

Scheduled endoscopic surveillance controls secondary cancer after curative endoscopic resection for early gastric cancer: A multicentre retrospective cohort study by Osaka University ESD study group

机译:计划内镜监测可控制早期胃癌根治性内镜切除术后继发性癌症:大阪大学ESD研究小组进行的多中心回顾性队列研究

获取原文
获取原文并翻译 | 示例
           

摘要

Background: After endoscopic submucosal dissection (ESD) of early gastric cancer (EGC), patients are at high risk for synchronous or metachronous multiple gastric cancers. Objective: To elucidate the time at which multiple cancers develop and to determine whether scheduled endoscopic surveillance might control their development. Design: A multicentre retrospective cohort study from 12 hospitals was conducted. Patients with EGC who underwent ESD with en bloc margin-negative curative resection were included. Synchronous cancer was classified as concomitant cancer or missed cancer. The cumulative incidence of metachronous cancers and overall survival rate were calculated using the Kaplan-Meier method. Results: From April 1999 to December 2010, 1258 patients met the inclusion criteria. Synchronous or metachronous multiple cancers were detected in 175 patients (13.9%) during a mean of 26.8 months. Among the 110 synchronous cancers, 21 were missed at the time of the initial ESD. Many of the missed lesions existed in the upper third of the stomach and the miss rate was associated with the endoscopist's inexperience (<500 oesophagogastroduodenoscopy cases). The cumulative incidence of metachronous cancers increased linearly and the mean annual incidence rate was 3.5%. The incidence rate did not differ between patients with or without Helicobacter pylori eradication. Four lesions (0.32%) were detected as massively invading cancers during the follow-up. Conclusions: Nineteen per cent of synchronous cancers were not detected until the initial ESD. The incidence rate of metachronous cancer after ESD was constant. Scheduled endoscopic surveillance showed that almost all recurrent lesions were treatable by endoscopic resection.
机译:背景:早期胃癌(EGC)的内镜黏膜下剥离术(ESD)后,患者发生同步或异时性多发胃癌的风险较高。目的:阐明多种癌症的发生时间,并确定定期的内窥镜监测是否可以控制其发展。设计:进行了来自12家医院的多中心回顾性队列研究。包括接受ESD整体边缘阴性根治性切除术的EGC患者。同步癌被分类为伴随癌或漏诊癌。异时癌症的累积发生率和总生存率使用Kaplan-Meier方法计算。结果:从1999年4月到2010年12月,有1258例患者符合纳入标准。平均26.8个月内,在175例患者(13.9%)中发现了同步或异时性多种癌症。在110例同时发生的癌症中,初次ESD时漏诊了21例。许多漏诊的病变存在于胃的上三分之一,漏诊率与内镜医师的经验不足有关(<500例食管胃十二指肠镜检查病例)。异时癌症的累积发病率呈线性增加,年平均发病率为3.5%。在有或没有根除幽门螺杆菌的患者之间,发病率没有差异。在随访期间发现了四个病变(0.32%)为大规模侵袭性癌症。结论:直到最初的ESD之前,未检测到19%的同步癌。 ESD后异时癌症的发生率是恒定的。定期的内窥镜监测显示,几乎所有复发性病变均可通过内窥镜切除术治疗。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号